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a b s t r a c t
The herpes simplex virus type 1 (HSV-1) tegument proteins pUL36 (VP1/2) and pUL37 are essential for
viral egress. We previously deﬁned a minimal domain in HSV-1 pUL36, residues 548–572, as important
for binding pUL37. Here, we investigated the role of this region in binding to pUL37 and facilitating viral
replication. We deleted residues 548–572 in frame in a virus containing a mRFP tag at the N-terminus of
the capsid protein VP26 and an eGFP tag at the C-terminus of pUL37 (HSV-1pUL36Δ548-572). This
mutant virus was unable to generate plaques in Vero cells, indicating that deletion of this region of
pUL36 blocks viral replication. Imaging of HSV-1pUL36Δ548-572-infected Vero cells, in comparison to
parental and resucant, revealed a block in secondary envelopment of cytoplasmic capsids. In addition,
immunoblot analysis suggested that failure to bind pUL37 affected the stability of pUL36. This study
provides further insight into the role of this essential interaction.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Herpes simplex type 1 (HSV-1) has a linear double stranded
DNA genome of approximately 152 kb, which is enclosed in an
icosahedral-shaped capsid. This capsid is encased in an amorphous
layer of protein termed the tegument, which is in turn enclosed in
a glycoprotein-containing host cell membrane-derived envelope
(Roizman et al., 2007). The HSV-1 tegument layer consists of at
least 23 virally-encoded proteins (Loret et al., 2008; Mettenleiter,
2004; Roizman et al., 2007) with both structural and non-
structural functions (Guo et al., 2010; Kelly et al., 2009). The inner
tegument proteins pUL36 and pUL37 are conserved across all
members of the Herpesviridae family (Kelly et al., 2009). For HSV-1
and the related Pseudorabies virus (PrV) in cell lines, deletion of
the genes encoding either of these proteins blocks secondary
envelopment of capsid and virion maturation (Desai et al., 2001;
Desai, 2000; Fuchs et al., 2004; Klupp et al., 2001; Leege et al.,
2009; Roberts et al., 2009; Sandbaumhuter et al., 2013; Schipke
et al., 2012).
pUL36 has several roles in both early and late stages of the
replication cycle. Essential and nonessential functional domains of
PrV pUL36 have been delineated using a combination of random
and directed deletion mutagenesis (Fig. 1A) (Bottcher et al., 2007,
2006; Mohl et al., 2010). pUL36 is involved in targeting of
incoming capsids to the nucleus and release of the viral genome
into the nucleus, where DNA transcription and replication occur
(Abaitua et al., 2012; Batterson et al., 1983; Batterson and Roizman,
1983; Delboy et al., 2008; Jovasevic et al., 2008; Knipe et al., 1979;
Roberts et al., 2009; Schipke et al., 2012). It is required for
intracellular capsid transport during egress (Luxton et al., 2006;
Shanda and Wilson, 2008) and is thought to be a receptor for
molecular motors (Radtke et al., 2010; Wolfstein et al., 2006;
Zaichick et al., 2013). Binding sites for both the inner tegument
protein pUL37 and the major tegument protein VP16 have been
identiﬁed in the N-terminal region of the protein (Klupp et al.,
2002; Ko et al., 2010; Mijatov et al., 2007; Vittone et al., 2005),
while the C-terminus contains two experimentally conﬁrmed
binding sites for the capsid protein pUL25 and a proposed binding
site for capsid protein VP5 (Fig. 1A) (Coller et al., 2007; Pasdeloup
et al., 2009; Schipke et al., 2012). Thus, pUL36 appears to form
a bridge between the capsid and the remainder of the tegu-
ment (Cardone et al., 2012; Ko et al., 2010). In the case of PrV,
the N-terminal region of pUL36 has also been shown to mediate
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nuclear egress (Leelawong et al., 2012). Other subdomains within
the N-terminal region of the protein include a nuclear localisation
signal (Abaitua et al., 2012; Abaitua and O'Hare, 2008) and a
deubiquitinating activity (Fig. 1A) (Bolstad et al., 2011; Kattenhorn
et al., 2005; Schlieker et al., 2005).
Like its binding partner pUL36, the 120 kDa protein pUL37 is also
multifunctional in nature. In HSV-1 and PrV pUL37 increases the
efﬁciency of transport of capsids to the nucleus, but is not essential for
this process (Krautwald et al., 2009; Luxton et al., 2006). While a role
in nuclear egress of HSV-1 could not be demonstrated (Leege et al.,
2009; Roberts et al., 2009; Sandbaumhuter et al., 2013), it is required
to direct capsids to the site of secondary envelopment (Pasdeloup
et al., 2010; Sandbaumhuter et al., 2013). pUL37 coelutes with the
single-stranded DNA binding protein ICP8 (Shelton et al., 1994), and in
the case of HSV-2 pUL37, a functional nuclear export signal has been
identiﬁed (NES) (Watanabe et al., 2000). HSV-1 pUL37 binds to a
number of cellular proteins, including TNF receptor-associated factor
6 (TRAF 6), with resulting activation of NF-κB signalling pathways
(Liu et al., 2008), the serine/threonine kinase thousand and one
kinase 3 (TAOK3), which belongs to the Ste20 kinase superfamily
(Kelly et al., 2012a; Strange et al., 2006), and dystonin, a spectraplakin
protein involved in microtubule-based transport (McElwee et al.,
2013; Pasdeloup et al., 2013). It is known to contain self-association
domains within the N and C-terminus regions as well as a pUL36
binding domain in the C-terminal region (Bucks et al., 2011).
Binding of pUL37 is thought to occur through a direct interac-
tion with pUL36, a feature which is conserved across the Herpes-
viridae family (Bechtel and Shenk, 2002; Klupp et al., 2002; Lee
Fig. 1. Domains of HSV-1 pUL36. (A) Diagram outlining identiﬁed domains of pUL36 including: a deubiquitinating (DUB) enzyme activity in the N-terminus (Kattenhorn
et al., 2005); a binding site for VP16 (Mijatov et al., 2007); a binding site for pUL37 (Klupp et al., 2002; Mijatov et al., 2007; Vittone et al., 2005); a proposed binding site for
the major capsid protein VP5 (Baker et al., 2006); a nonessential internal region based on a study with the related Pseudorabies virus (PrV) (Bottcher et al., 2006); and two
binding sites for capsid protein pUL25 (Coller et al., 2007; Pasdeloup et al., 2009; Schipke et al., 2012). (B) Alignment of the pUL37 binding site of pUL36 homologues within
the Alphaherpesvirinae subfamily (McGeoch et al., 2006). The majority of conserved residues were targeted for mutagenesis (highlighted in bold) in a previous study from our
laboratory (Mijatov et al., 2007). Family members include HSV-1 strain 17 and F, HSV-2, Simian agent 8 (SA8), B virus (HVB), Bovine herpesvirus 1 (BHV-1), Bovine
herpesvirus 5 (BHV-5), PrV, Equine herpesvirus 1 (EHV-1), Equine herpesvirus 4 (EHV-4), Varicella-zoster virus (VZV), Simian varicella virus (SVV), Marek's disease virus type
1 (MDV-1), Marek's disease virus type 2 (MDV-2), Herpesvirus of Turkey (HVT), infectious laryngotracheitis virus (ILTV) and Psittacid herpesvirus 1 (PsHV-1). The encoded
pUL36 sequences were obtained from the following herpesviral genome sequence accession numbers: HSV-1 strain 17, X14112; HSV-1 strain F, GU734771; HSV-2, Z86099;
SA8, AY714813; HVB, AF533768; BHV-1, AJ004801; BHV-5, AY261359; PrV, BK001744; EHV-1, AY665713; EHV-4, AF030027; VZV, X04370; SVV, AF275348; MDV-1, AF24338;
MDV-2, AB049735; HVT, AF291866; ILTV, AF168792; PsHV-1, AY372243. Clustal W alignments were generated using Lasergene version 11.1 MegAlign from DNASTAR.
(C) Diagram of pUL36 constructs expressed with a C-terminal GFP tag in this study.
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et al., 2008; Rozen et al., 2008; Stellberger et al., 2010; To et al.,
2011; Uetz et al., 2006; Vittone et al., 2005). In the case of HSV-1,
residue D631 in the C-terminal pUL36 binding domain of pUL37 is
essential for binding pUL36 (Kelly et al., 2012b). Deletion of UL36
results in cytosolic capsids devoid of pUL37 (Klupp et al., 2002;
Sandbaumhuter et al., 2013). The deletion of pUL36 also blocks
trafﬁcking of pUL37 to sites of secondary envelopment in a capsid
independent manner, suggesting a role for the interaction
between these two proteins in incorporation into the virion
(Desai et al., 2008).
The pUL37-binding domain in pUL36 is located in the N-terminus
of the protein (Klupp et al., 2002; Mijatov et al., 2007). A previous
study on PrV pUL36 indicated that the interaction of pUL36 and
pUL37 was important but not essential for secondary envelopment
during virion assembly (Fuchs et al., 2004). This is not surprising
since PrV pUL36 is essential for viral replication (Fuchs et al., 2004)
but pUL37 is not essential (Klupp et al., 2001). In contrast, for HSV-1
both pUL36 and pUL37 are essential for replication (Desai et al.,
2001; Desai, 2000; Roberts et al., 2009; Sandbaumhuter et al., 2013;
Schipke et al., 2012) but to date no study has directly assessed the
role of the interaction of these key tegument proteins in HSV-1
replication. In this study, we therefore sought to deﬁne the role of
the interaction of pUL36 with pUL37 by examining the effects of
deleting the pUL37 binding domain in pUL36 on the replication of
HSV-1.
Results
Conﬁrmation of the pUL37 binding site in pUL36
Our previous study found the binding region of pUL37 in HSV-1
pUL36 to lie within the N-terminal region of pUL36 (Fig. 1A)
(Vittone et al., 2005). A similar observation has been reported for
pUL36 in PrV and VZV (Klupp et al., 2002; Stellberger et al., 2010).
A subsequent study by our laboratory identiﬁed a number of
conserved residues within amino acid residues 548–572 (strain F
numbering; equivalent to amino acids 578–602 in strain 17) that
are involved in binding of pUL36 to pUL37 (Fig. 1B; (Mijatov et al.,
2007)). To investigate further the role of this region in virus
replication we had to conﬁrm the requirement for this region for
binding to pUL37. We deleted pUL36 amino acid residues 548–572
in a GFP-tagged fragment of pUL36 (pUL36N2-GFP; strain F amino
acids 482–737) (Fig. 1C). We then tested the ability of this mutated
fragment, pUL36N2Δ548-572-GFP, to bind myc-tagged pUL37
(myc-pUL37). HeLa cells were cotransfected with myc-pUL37 and
pUL36N2-GFP, pUL36N2Δ548-572-GFP or pUL36N1-GFP. The
pUL36N1-GFP fragment consists of a region of pUL36 (strain F
amino acids 292–481) adjacent to the pUL37 binding site (Fig. 1C)
and was included as a negative control. Cell lysates were harvested
at 24 h post transfection and coimmunoprecipitation using anti-
myc antibody was carried out. Immunoblot analysis conﬁrmed the
presence of myc-pUL37 (Fig. 2A, top panel) and of each pUL36-GFP
fragment in input lysates and elutes (Fig. 2A, bottom panel)., Only
pUL36N2-GFP precipitated with myc-pUL37 (Fig. 2A, bottom
panel). When residues 548–572 were deleted, the GFP-tagged N2
fragment of pUL36 failed to bind myc-pUL37 (Fig. 2A, bottom
panel). This conﬁrms that the 548–572 region (Fig. 1B) of pUL36 is
crucial for binding of pUL37.
We noted that in our input lysates (Fig. 2A, bottom panel) the
level of pUL36N2-GFP detected was higher than that of
pUL36N2Δ548-572-GFP when each was cotransfected with myc-
pUL37, although there were still adequate expression levels of
pUL36N2Δ548-572-GFP to establish it no longer binds pUL37
(Fig. 2A, bottom panel). Our previous study, which deﬁned
pUL37 amino acid D631 to be critical for binding of pUL36,
reported reduced levels of both pUL36N2-GFP and full-length
pUL36 when pUL37 was absent or when binding of pUL37 to
pUL36 was disrupted (Kelly et al., 2012b). It appeared that a similar
effect was being seen here. To conﬁrm this, we carried out another
cotransfection experiment. HeLa cells were cotransfected with
pUL36N2-GFP, pUL36N2Δ548-572-GFP, or pUL36N1-GFP and
myc-pUL37 or myc-Filamin (chosen as a negative control since it
has a similar size to pUL37). Immunoblot analysis of transfected
cell lysates using anti-myc antibody showed similar levels of myc-
pUL37 and myc-Filamin expressed in each sample (Fig. 2B, top
panel). Detection with an anti-GFP antibody showed that higher
levels of pUL36N2-GFP were detected when this construct was
cotransfected with myc-pUL37 compared with cotransfection with
myc-Filamin, while levels of pUL36N2Δ548-572-GFP remained
similar when contransfected with either myc-pUL37 or myc-
Filamin (Fig. 2B, bottom panel). When bands were quantiﬁed
and the results normalised to myc-pUL37 levels, the amount of
pUL36N2-GFP was 2.6 fold higher than that of pUL36N2Δ548-
572-GFP when myc-pUL37 was present. This further conﬁrms
our ﬁnding that binding of pUL37 to this region of pUL36
stabilises pUL36.
Construction and initial characterisation of recombinant HSV-1
viruses
To investigate the importance of residues 548–572 in the
context of viral replication, the region of UL36 encoding residues
548–572 was deleted in a HSV-1F strain virus with an mRFP tag
at the N-terminus of capsid protein pUL35 (VP26) and an eGFP
tag at the C-terminus of pUL37 (Fig. 3A). All modiﬁcations
were introduced using BAC recombination as previously described
(de Oliveira et al., 2008). The resulting mutant virus was termed
HSV-1FpUL36Δ548-572, while the parental virus expressing the
ﬂuorescent tags was designated HSV-1FR3537G. A rescuant virus
was constructed by homologous recombination restoring the
pUL36 coding region to the wild type sequence. The rescuant
was termed HSV-1FpUL36Δ548-572R.
The kinetics of virus production by HSV-1F, HSV-1FR3537G,
HSV-1FpUL36Δ548-572 and HSV-1FpUL36Δ548-572R was exam-
ined in Vero cells. Cells were infected at an MOI of 10 pfu/cell.
Extracellular and cell associated virus titres were analysed sepa-
rately at 4, 8, 16 and 24 h p.i. For both extracellular and cell
associated virus, titres of HSV-1FR3537G and HSV-1FpUL36Δ548-
572R were approximately 1 log lower than that of the wild type,
HSV-1F (Fig. 3B). This is similar to what has been found previously
for ﬂuorescently tagged HSV-1 F-strain (de Oliveira et al., 2008)
and is most likely due to fusion of the RFP tag to VP26 which has
previously been reported to result in formation of nuclear aggre-
gates of VP26 and to subsequently impair capsid nuclear egress
(Nagel et al., 2012). Titres of HSV-1FpUL36Δ548-572 were sig-
niﬁcantly reduced compared to all three other viruses (Fig. 3B),
indicating a similar attenuation to that previously reported for
HSV-1 pUL37 deletion mutants (Desai et al., 2001; Leege et al.,
2009; Roberts et al., 2009; Sandbaumhuter et al., 2013). The
magnitude of the defect in HSV-1FpUL36Δ548-572 attributable
to the deletion in pUL36 may be less than it appears due to the
presence of the ﬂuorescent tags.
Plaque morphology of the mutant virus was compared to that
of the parental and the rescuant. Both Vero cells and pUL36
complementing cells (HAUL36-1) on coverslips were infected with
HSV-1FR3537G, HSV-1FpUL36Δ548-572 or HSV-1FpUL36Δ548-
572R. Cells were ﬁxed after 3 days and plaque morphology was
observed by ﬂuorescent microscopy. While HSV-1FR3537G and
HSV-1FpUL36Δ548-572R formed similar sized plaques in both cell
lines (Fig. 3C), HSV-1FpUL36Δ548-572 only formed plaques in the
complementing cell line (Fig. 3C). While individual Vero cells
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expressing ﬂuorescently tagged viral proteins were observed for
HSV-1FpUL36Δ548-572 infections, the virus was unable to spread
from the initially infected cells (Fig. 3C). Together these observa-
tions suggest that the deletion of pUL36 residues 548–572 blocks
spread of the virus from one cell to the next. The fact that the
rescuant virus exhibited similar growth kinetics and plaque
morphology to that of the parental virus, conﬁrms that the pheno-
type observed for HSV-1FpUL36Δ548-572 in non-complementing
cells is solely due to the Δ548–572 mutation and not to a mutation
present somewhere else in the genome.
Next we looked at levels of pUL37 and pUL36 in virus-infected
cell lysates. We infected Vero cells with HSV-1FR3537G or HSV-
1FpUL36Δ548-572 at an MOI of 10 pfu/cell and harvested infected
cell lysates at 24 h p.i. Immunoblot analysis was carried out using
antibodies against GFP and pUL36 (Fig. 4). The pUL37-GFP protein
was detected in both HSV-1R3537G- and HSV-1FpUL36Δ548-572-
infected cell lysates (Fig. 4, top panel), however, we observed
essentially no full-length pUL36 in HSV-1FpUL36Δ548-572-
infected cell lysates when compared with HSV-1FR3537G-
infected lysates (Fig. 4, bottom panel). This is based on a predicted
molecular mass for full-length pUL36 of 332.9 kDa for WT com-
pared to 330 kDa for Δ548–572. The absence of full-length pUL36
was not a result of deletion of the epitope for pUL36 in HSV-
1FpUL36Δ548-572 as the polyclonal anti-pUL36 antibody was
raised against an expression product corresponding to amino acids
1845 to 2001 (strain F numbering) of HSV-1 pUL36 (Thomas
Mettenleiter, personal communication). Our inability to detect
the full length protein may instead be due to its inherent
instability in the absence of pUL37 binding, as seen above for
the GFP-tagged pUL36 fragments and in our previous study (Kelly
et al., 2012b). For both HSV-1FR3537G and HSV-1FpUL36Δ548-
572 we observed major proteolytic fragments of pUL36 at
270 kDa and 60 kDa (Fig. 4, bottom panel). Proteolysis of the
N-terminus of pUL36 has been previously documented (Bolstad
et al., 2011; Jovasevic et al., 2008; Leelawong et al., 2012; Schipke
et al., 2012). Therefore, the 270 kDa pUL36 fragment most likely
corresponds to proteolysis of the N-terminus which would be
sufﬁcient to remove the pUL37 binding domain.
Electron microscopy
To determine the point at which replication of the mutant virus
was being blocked, we infected Vero cells with HSV-1FR3537G,
HSV-1FpUL36Δ548-572 or HSV-1FpUL36Δ548-572R, ﬁxed cells at
23 h p.i., and analysed samples by electron microscopy. For both
HSV-1FR3537G (Fig. 5A–C) and HSV-1FpUL36Δ548-572R (Fig. 5D–
E) virion maturation occurred as normal. Cytosolic capsids and all
stages of secondary envelopment of particles in the cytoplasm
were observed in each case (Fig. 5A, B and D), as were fully mature
extracellular virions (Fig. 5C and E). For cells infected with HSV-
1FpUL36Δ548-572 (Fig. 6), capsids successfully exited the nucleus
by primary envelopment (Fig. 6B) and de-envelopment, or they
may have gained access to the cytoplasm via impaired nuclear
pores (Leuzinger et al., 2005). However, once in the cytoplasm,
capsids appeared to remain there with no evidence of secondary
envelopment (Fig. 6A, C and D). Instead of extracellular mature
virions, capsidless membrane-bound electron dense particles were
observed (Fig. 6D and E) which were recognised as L-particles
since they were not found in uninfected cells (not shown). This is
comparable to the phenotype of pUL36 and pUL37 deletion
mutants (Desai et al., 2001; Desai, 2000; Fuchs et al., 2004;
Klupp et al., 2001; Leege et al., 2009; Roberts et al., 2009;
Sandbaumhuter et al., 2013), suggesting that if pUL37 does not
Fig. 2. Amino acid residues 548–572 of pUL36 are required for binding of pUL37. (A) HeLa cells were cotransfected with the indicated constructs and harvested at 24 h post
transfection. A coimmunoprecipitation assay was carried out. Mouse IgG whole molecule agarose was incubated with mouse anti-myc antibody before incubation with cell
lysates. Input lysates and immunoprecipitated proteins were analysed by 12% SDS-PAGE and immunoblotting using rabbit anti-myc antibody (top panel) and rabbit anti-GFP
antibody (bottom panel). (B) HeLa cells were cotransfected with the indicated constructs to further assess stabilisation of pUL36 by bound pUL37. Cell lysates were harvested
at 24 h post transfection and analysed by 10% SDS-PAGE and immunoblot using anti-myc (top panel) and anti-GFP (bottom panel) antibodies.
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bind to pUL36 the effect is similar to the absence of pUL37 i.e. a
block in secondary envelopment.
Confocal microscopy
The subcellular localisation of pUL37 during viral egress was
analysed by ﬂuorescent microscopy (Fig. 7). Vero cells were
infected with the parental HSV1-1FR3537G, the mutant strain
HSV-1FpUL36Δ548-572, or the recuant HSV-1FpUL36Δ548-572R,
ﬁxed at 12 or 23 h p.i., and analysed by confocal laser scanning
microscopy. At the earlier time point, 12 h p.i., only about 10% of
the cells had mRFP-VP26 in the nucleus, indicating virus produc-
tion. We restricted our analysis to those cells. In all analysed
cells infected with the parental HSV1-1FR3537G (Fig. 7A) or the
rescuant HSV-1FpUL36Δ548-572R (Fig. 7C) we identiﬁed capsids
in the cytoplasm by their mRFP-VP26 signals which colocalised
with pUL37-GFP. This suggests that pUL37 is bound to capsids,
presumably via an interaction with pUL36, which has previously
been shown to be required for incorporation of pUL37 into capsids
(Ko et al., 2010; Sandbaumhuter et al., 2013). In contrast the
majority of cytoplasmic capsids in cells infected with the deletion
mutant HSV-1FpUL36Δ548-572 did not colocalise with pUL37-
Fig. 3. Characterisation of recombinant viruses. (A) Diagram indicating the modiﬁcations introduced into HSV-1 F strain genome. The parental virus, HSV-1FR3537G,
produced by BAC recombination has an mRFP tag at the N-terminus of capsid protein VP26 (pUL35) and a eGFP tag at the C-terminus of tegument protein pUL37. In this
background, a deletion of residues 548–572 in pUL36 (Δ) was engineered by BAC recombination to produce HSV-1FpUL36Δ548-572. A rescuant, HSV-1FpUL36Δ548-572R,
was subsequently generated from HSV-1FpUL36Δ548-572 using standard homologous recombination. The direction of the arrowhead indicates the direction of gene
transcription for the gene in question. TRL, terminal repeat of the long segment; IRL, internal repeat of the long segment; IRS, internal repeat of the short segment; TRS,
terminal repeat of the short segment. (B) For growth kinetics, Vero cells were infected at an MOI of 10 pfu/cell with HSV-1F (◆), HSV-1FR3537G (■), HSV-1FpUL36Δ548-572
(▲) or HSV-1FpUL36Δ548-572R (●). Cell associated virus and extracellular virus was harvested at the indicated timepoints and viral titres were estimated by plaque assay.
(C) For plaque morphology, HAUL36-1 cells (left panel) or Vero cells (right panel) on coverslips were infected with serial dilutions of the indicated viruses. After infection
with virus, cells were overlaid with a semi solid overlay and incubated for 3 days before being ﬁxed and viewed using a confocal microscope. Green ﬂuorescence represents
pUL37-GFP, while red ﬂuorescence represents mRFP-VP26. Scale bars equal 40 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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GFP (Fig. 7B). At 23 h p.i. more cells displayed virus production.
Capsid and pUL37 signals accumulated in a juxtanuclear location
in addition to individual capsids outside this juxtanuclear location
(data not shown). Similar to the 12 h p.i. condition the latter did
colocalise with pUL37-GFP in the parental and rescuant strains
while in the mutant strain many of these capsid signals did not
colocalise with the signals for pUL37. This observation, like our EM
ﬁndings, indicates a block in secondary envelopment, causing a
build up of capsids and sequestering of tegument proteins at sites
where this process would normally take place.
Discussion
Previous work carried out in our laboratory identiﬁed an
interaction between HSV-1 pUL36 and pUL37 and mapped the
binding site for this interaction to an N-terminal region of pUL36
(Vittone et al., 2005). We subsequently deﬁned a number of
conserved residues within this region that are critical to this
interaction and postulated that the minimal binding domain for
pUL37 resides within pUL36 residues 578–602 in HSV-1 strain 17
(residues 548–572 in HSV-1 strain F; Fig. 1B) (Mijatov et al., 2007).
In this report we initially conﬁrmed that the binding site of pUL37
in pUL36 does indeed reside within this region of conserved
residues. We also noted that there was disparity in the levels of
pUL36N2-GFP and pUL36N2Δ548-572-GFP detected when each
was cotransfected with myc-pUL37. When the 548–572 region was
present and the pUL36N2-GFP fragment bound to myc-pUL37,
more of this fragment was detected in lysates compared to
pUL36N2Δ548-572-GFP, which was shown by coimmunopreci-
pitation not to bind to myc-pUL37. This effect was conﬁrmed
by cotransfecting myc-pUL37 or a myc-Filamin control with
pUL36N2-GFP, pUL36N2Δ548-572-GFP or pUL36N1(residues
292–481)–GFP. Thus, when this fragment of pUL36 is prevented
from binding to pUL37 it appears to be degraded, suggesting that
binding of pUL37 to pUL36 plays a role in stabilising the protein.
The role of pUL36 residues 548–572 in the context of viral
replication was then ascertained. When virus infected cell lysates
were analysed by immunoblot, no full-length pUL36 was detected
for the mutant virus, HSV-1FpUL36Δ548-572 which had the
pUL37 binding site deleted, compared to the parental virus, HSV-
1FR3537G. We also observed a reduction of pUL36 in our previous
study with a single amino acid mutant of the pUL36 binding site in
pUL37 (D631A) (Kelly et al., 2012b), indicating that the phenom-
enon is not speciﬁc to the BAC derived HSV-1F strain mutant,
HSV-1FpUL36Δ548-572, used here. A similar effect has been
reported for the pUL36 homologue in HCMV, pUL48 (Bechtel and
Fig. 4. Increased proteolysis and reduced expression levels of pUL36 in the absence
of bound pUL37. Vero cells were infected with the indicated viruses. Viral lysates
were harvested at 24 h p.i. and analysed by SDS-PAGE and immunoblot using
antibodies against GFP (top panel) and pUL36 (bottom panel). Full-length
(pUL36FL) and predominant proteolytic fragments (pUL36f) of pUL36 are indicated.
Fig. 5. HSV-1FR3537G and HSV-1FpUL36Δ548-572R capsids undergo secondary
envelopment. Vero cells were infected with the parental strain HSV-1FR3537G (a–c)
or HSV-1FpUL36Δ548-572R (d–e), ﬁxed at 23 h p.i., and analysed by electron
microscopy. Black arrows (a, b, and d) indicate cytoplasmic virions after complete
secondary envelopment or extracellular virions (c and e). Black arrowheads indicate
wrapping intermediates of secondary envelopment (a, b, and d). Scale bars equal
200 nm.
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Shenk, 2002). Lower levels of pUL48 protein were detected in cells
infected with a virus that did not express the pUL37 homologue
pUL47, compared with levels in wild type infected cells. The steady
state level of pUL48 RNA was shown to be unaffected by the
mutation in pUL47, suggesting the level of pUL48 is reduced in the
mutant virus at a translational or posttranslational level (Bechtel
and Shenk, 2002). A study to characterise the deubiquitinating
activity within the N-terminus of HSV-1 pUL36 found that trans-
fected N-terminal variants of pUL36, in particular fragments
encompassing the pUL37 binding site, were dependent upon the
pUL36 deubiquitinating enzyme activity for accumulation (Bolstad
et al., 2011). Unstable variants were stabilised not only by protea-
some inhibition, but also by virus infection, indicating a possible
role for interaction of protein partners in masking ubiquitination
sites or altering protein folding, thus stabilising pUL36 (Bolstad
et al., 2011). Our observations here suggest that the binding of
pUL37 may play such a role in stabilising pUL36 and in the absence
of bound pUL37 there is increased proteolysis of the N-terminal
domain of pUL36. Future studies with proteasomal inhibitors such
as MG132 will provide further insight into the role of pUL37 in
stabilizing pUL36 during HSV-1 replication.
Analysis of growth kinetics, plaque morphology and the use of
electron microscopy indicated a block in virion secondary envel-
opment with an accumulation of cytosolic capsids when the
pUL36Δ548-572 mutation was present. The phenotype was simi-
lar to that of pUL36 and pUL37 deletion mutants in both HSV-1
and PrV, (Desai et al., 2001; Desai, 2000; Fuchs et al., 2004; Klupp
et al., 2001; Leege et al., 2009; Roberts et al., 2009;
Sandbaumhuter et al., 2013). Fluorescent microscopy revealed that
many individual cytosolic capsids of the mutant virus did not
colocalize with pUL37 most likely because the mutant pUL36 no
longer bound pUL37. With the progression of infection juxta-
nuclear regions accumulated high levels of capsid and pUL37,
suggesting that the block in secondary envelopment leads to a
build up of capsid and tegument proteins at sites where this
process should take place. Recruitment of pUL37 to sites of
secondary envelopment is known to be independent of capsid
but to require pUL36 (Desai et al., 2008). Future studies examining
whether capsid and pUL37 colocalize with cellular markers to
intracellular membranes will ultimately conﬁrm that the pheno-
type observed for HSV-1FpUL36Δ548-572 is similar to previous
studies with pUL36/pUL37 deletion mutants. Once at the site of
secondary envelopment the interaction of pUL36 with pUL37 is
essential to drive acquisition of the outer tegument and secondary
envelope. In summary, this report deﬁnes the region of pUL36
required for binding of its inner tegument protein pUL37 and
demonstrates that interaction of these two proteins is essential for
secondary envelopment to occur.
Materials and methods
Cell culture and viruses
Vero cells and HeLa cells were maintained in Dulbecco's
modiﬁed Eagle medium (DMEM) (Invitrogen) supplemented with
10% (v/v) foetal bovine serum (FBS) (JRH Bioscience). The pUL36
complementing cell line (HAUL36-1; kindly provided by Frazer
Rixon, MRC Virology unit, University of Glasgow, Glasgow, United
Kingdom; (Roberts et al., 2009)) was maintained in DMEM
supplemented with 10% FBS, 1x non-essential amino acids (NEAAs)
(Invitrogen), and 0.5 mg/ml of Geneticin (Invitrogen). All cells
were grown at 37 1C (5% CO2). The HSV-1F virus (wild type strain
F), the parental virus HSV-1FR3537G and the rescuant virus HSV-
1FpUL36Δ548-572R were propagated in Vero cells. The pUL36
mutant virus HSV-1FpUL36Δ548-572 was propagated in HAUL36-
1 cells. In this study we use HSV-1F strain pUL36 amino acid
numbering (Szpara et al., 2010) (total length 3134 amino acids)
when referring to our recombinant viruses since they were made
in an F strain background. The deleted region of pUL36 (amino
acid residues 548–572) is equivalent to the previously determined
pUL37 binding site in pUL36 (HSV-1 strain 17, amino acid residues
578–602) (Fig. 1B) (Mijatov et al., 2007). For virus infections, virus
inocula were prepared in DMEM supplemented with 2% FBS and
1% penicillin and streptomycin (P/S), with or without NEAA and
geneticin, depending on the cell line, and plated onto cells in
monolayers for 1 h at 37 1C, unless otherwise speciﬁed. After this
time fresh DMEM, supplemented as for inocula, was added. For
transient transfections, HeLa cells were grown to 80% conﬂuency
in 6 well plates. Cells were transfected using Lipofectamine 2000
transfection reagent (Invitrogen) according to the manufacturer's
instructions.
Expression constructs
The HSV-1 full length UL37 ORF encoding amino acids 1–1123
cloned into pCMVmyc has been previously described (Vittone et al.,
2005). The pUL36 fragments corresponding to amino acids 317–511
and 512–767 (HSV-1 strain 17 amino acid numbering (McGeoch
et al., 1988)) cloned into pEGFP-N1 have been previously described
(pUL36N1-GFP and pUL36N2-GFP, respectively; (Kelly et al.,
2012b)). The pUL36 N1 and N2 constructs correspond to HSV-1
strain F pUL36 residues 292–481 and 482–737 respectively. An
in-frame deletion of pUL36 residues 548–572 (strain F numbering;
corresponding to strain 17 amino acids 578–602) was introduced
Fig. 6. HSV-1FpUL36Δ548-572 mutant capsids do not undergo secondary envelop-
ment. Vero cells were infected with HSV-1FpUL36Δ548-602, ﬁxed at 23 h p.i., and
analysed by electron microscopy. Black arrowheads indicate cytosolic capsids (a–d)
that appeared to have left the nucleus (N) by primary envelopment (b) and de-
envelopment. No cytoplasmic capsids associated with membrane, or extracellular
virions, were observed. Instead many capsidless L-particles were detected (d–e,
black arrows). Scale bars equal 200 nm.
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Fig. 7. HSV-1FpUL36Δ548-572 capsids do not colocalise with cytosolic pUL37-GFP. Vero cells were infected with the parental HSV1-1FR3537G (A), the mutant HSV-
1FpUL36Δ548-572 (B), or the recuant HSV-1FpUL36Δ548-572R (C), ﬁxed at 12 h p.i., and analysed by confocal laser scanning microscopy. The pUL37-GFP channel is shown
in (Ai) to (Ci), the mRFP-VP26 is shown in (Aii) to (Cii), and the merge of both channels is shown in (Aiii) to (Ciii). Insets represent the indicated areas scanned at higher
magniﬁcation and pixel resolution. Scale bars equal 5 mm. To evaluate the degree of colocalisation (Aiv–Civ) ﬂuorescence was measured along a line highlighted by the
arrows and plotted as grey values (green¼pUL37-GFP, red¼mRFP-VP26) against the length of the line in mm. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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into pUL36N2-GFP using the QuikChanges II XL Site-Directed
Mutagenesis Kit (Stratagene) to produce pUL36N2Δ548-572-GFP.
This region of pUL36 encompasses the pUL37 binding site (Fig. 1B)
(Mijatov et al., 2007). A fragment corresponding to amino acids
1779 to 2647 of Filamin A was cloned into the BamHI site of
pCMVmyc. All generated inserts in each expression construct were
conﬁrmed by sequencing.
Coimmunoprecipitation
Coimmunoprecipitations were performed as previously
described (Kelly et al., 2012b). Brieﬂy, cells were harvested at
24 h post transfection. Mouse anti-IgG (whole molecule) agarose
(Sigma) was incubated overnight with 5 μg of mouse anti-myc
antibody (Santa Cruz) at 4 1C with gentle rotation. The following
day, agarose beads were washed ﬁve times with PBS 0.1% (v/v)
Triton X-100. Cell lysates were added to the agarose beads and
incubated for 3 h at 4 1C with gentle rotation. Agarose beads were
harvested by spinning at 500g for 5 min and then washed 5 times
with 500 μl of wash buffer (PBS containing 0.1% (v/v) Triton
X-100). Protein complexes were then eluted into 50 μl of 2X
reducing SDS-PAGE sample buffer (Sigma) by heating at 95 1C for
5 min.
Analysis of protein complexes
Proteins were separated by SDS-PAGE and immunoblots were
processed as previously described (Kelly et al., 2012b; Vittone
et al., 2005). For immunoblots of pUL36, 6% SDS-PAGE was used.
Detection was performed with an Odyssey Infrared Imaging
system (Licor-Biosciences). Primary antibodies used included mouse
monoclonals against GFP (1:1000 dilution; Santa Cruz) and c-myc
(1:1000 dilution; Santa Cruz); and rabbit polyclonals against HSV-1
pUL36 (1:1000 dilution) and HSV-1 pUL37 (1:15,000 dilution) (both
kindly provided by Thomas Mettenleiter, Institute of Molecular
Biology, Friedrich-Loefﬂer-Institut, Greifswald-Insel Riems, Germany;
(Leege et al., 2009)). Secondary antibodies for the Odyssey system
included goat anti-mouse IRDye 680-conjugated IgG (1:12,000 dilu-
tion; Licor) and goat anti-rabbit IRDye 800-conjugated IgG (1:12,000
dilution; Licor).
Construction of recombinant viruses
The two recombinant HSV-1 viruses, HSV-1FR3537G and HSV-
1FpUL36Δ548-572, were generated by homologous recombina-
tion in Escherichia coli SW102 cells, and galK selection/counter-
selection (Warming et al., 2005) using a bacterial artiﬁcial
chromosome (BAC)-cloned HSV-1 parental strain F genome
(YEbac102; kindly provided by Yasushi Kawaguchi, Tokyo Medical
and Dental University, Japan; (Tanaka et al., 2003)). Introduction of
the mRFP tag at the N-terminus of capsid protein VP26, where
codons 1 to 225 of mRFP are fused to codons 5 to 108 of VP26, has
been previously described (de Oliveira et al., 2008). The introduc-
tion of a eGFP tag at the C-terminus of tegument protein pUL37
was carried out in a similar manner. Oligonucleotide primers
UL37galKF, UL37galKR, UL37GF and UL37GR were used to prepare
ﬁrst and second stage targeting cassettes for this modiﬁcation
(Table 1). To delete the fragment of UL36 encoding amino acids
548–572 oligonucleotide primers UL36Δ548-572galKF and
UL36Δ548-572galKR (Table 1) were used to prepare the ﬁrst stage
targeting cassette. These primers consisted of galK homology
ﬂanked by 50 bases homologous to either side of the desired
deletion in UL36, so that in the ﬁrst stage of recombination galK
replaced bases 78653–78727 of the pUL36 coding sequence. The
second stage targeting cassette consisted of the 100 bases homo-
logous to the HSV-1 strain F genome, either side of where galKwas
inserted. These 100 bp single stranded oligonucleotides,
UL36Δ548-572s and UL36Δ548-572as (Table 1), were heated to
100 1C and allowed to cool to room temperature (RT) for 30 min to
anneal. The DNA was ethanol precipitated and quantiﬁed by
running a sample on a 1% (w/v) agarose gel, alongside a known
molecular weight standard. For each electroporation, at least
200 ng of targeting cassette was used. Clones which had success-
fully replaced galK with the desired modiﬁcation were identiﬁed
by restriction enzyme analysis using Bsp119I digestion.
To release the viral genome from the BAC backbone, modiﬁed
HSV-1 BAC DNAwas cotransfected with a Cre recombinase-expressing
plasmid into Vero cells. In the case of HSV-1FpUL36Δ548-572,
cotransfections were carried out in the pUL36-complementing
HAUL36-1 cell line to compensate for any effect the deletion may
have on production of infectious virus. Once the HSV-1FpUL36Δ548-
572 mutant had been constructed a rescuant virus was prepared as
previously described (Roberts et al., 2009). Brieﬂy, oligonucleotide
primers RescUL36F and RescUL36R (Table 1), containing EcoRI restric-
tion enzyme sites, were used to PCR amplify a 2.7 kb region spanning
bases 77663–80388 of the wild type F strain pUL36 coding region,
which encompassed the region deleted in HSV-1FpUL36Δ548-572.
The resulting fragment was cloned into pUC18 plasmid to produce
the transfer vector pUC18-UL36resc. Vero cells were transfected
with pUC18-UL36resc before being infected with the mutant HSV-
1FpUL36Δ548-572 at a multiplicity of infection (MOI) of 1 pfu/cell.
Resulting virus was harvested from both cells and culture medium
and plaque puriﬁed on Vero cells to isolate rescued virus which
produced wild type plaques on this non-complementing cell line.
Once the mutant and rescuant had been prepared, viral DNA was
puriﬁed and used to sequence the pUL36 region of interest to
conﬁrm the presence or absence of the Δ548–572 deletion.
Growth kinetics
To assess the growth kinetics of each virus, Vero cells were
infected at an MOI of 10 pfu/cell. After 1 h incubation at 37 1C,
virus inocula were removed and cells were incubated at RT for
1 min with citric acid buffer (40 mM citric acid, 10 mM KCl,
135 mM NaCl [pH 3.0]) to inactivate any remaining, non-
penetrated virus. Citric acid buffer was removed, cells were
washed twice with PBS and fresh medium was added. Virus was
harvested at 4, 8, 16 and 24 h p.i. Supernatant containing extra-
cellular virus was removed and sonicated (60 s) before titration by
plaque assay. Infected cell monolayers were washed twice with
PBS before addition of 1 ml of fresh medium. Cells were scraped
into medium and sonicated 360 s before titration by
plaque assay.
Plaque morphology
Vero cells and HAUL36-1 cells were seeded on coverslips in 24
well plates. Serial dilutions of virus were prepared and plated.
After incubation for 2 h, virus inocula were removed and cells
were overlaid with a 1:1 solution of carboxymethylcellulose (CMC;
3.2%):DMEM supplemented with 2% FBS and 1% P/S. Cells were
ﬁxed at 72 h p.i. with 4% paraformaldehyde and coverslips were
mounted onto slides using Slowfades Gold antifade reagent
(Invitrogen). Plaque morphology was analysed using an Olympus
confocal laser scanning microscope. Image processing was carried
out using FV10-ASW (Olympus) and Adobe Photoshop software.
Electron microscopy
Vero cells were seeded onto coverslips 1 day prior to infection.
The cells were pre-cooled for 20 min on ice, and incubated with a
virus dose of 1 pfu/cell in CO2-independent medium containing
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0.1% (w/v) BSA for 2 h on ice on a rocking platform. The cells were
then shifted to regular growth medium at 37 1C and 5% CO2 for 1 h.
Non-internalised virus was inactivated by a short acid wash for
3 min (40 mM citrate, 135 mM NaCl, 10 mM KCl, pH 3), and the
cells were transferred back to regular growth medium. After 22 h,
the cells were ﬁxed with 2% (w/v) glutaraldehyde in 130 mM
cacodylate buffer at pH 7.4 containing 2 mM CaCl2 and 10 mM
MgCl2 for 1 h at room temperature. Subsequently the cells were
washed and postﬁxed for 1 h with 1% (w/v) OsO4 in 165 mM
cacodylate buffer at pH 7.4 containing 1.5% (w/v) K3[Fe(CN)6],
followed by 0.5% (w/v) uranyl acetate in 50% (v/v) ethanol over-
night. The cells were embedded in Epon, and 50 nm ultrathin
sections were cut parallel to the substrate. Images were taken with
an Eagle 4 k camera at a Tecnai G2 electron microscope at 200 kV
(FEI, Eindhoven, the Netherlands).
Confocal laser scanning microscopy
Vero cells were infected with the parental HSV1-1FR3537G, the
mutant HSV-1FpUL36Δ548-572, or the recuant HSV-
1FpUL36Δ548-572R as described for electron microscopy. At 12
or 23 h p.i. cells were ﬁxed with 3% paraformaldehyde in PBS for
20 min at room temperature and embedded with Prolong Antifade
(Invitrogen). Fluorescence microscopy was performed with a Zeiss
LSM510 confocal laser scanning microscope and a 63x objective,
NA 1.4; a pinhole aperture of 1 Airy unit. Lower magniﬁcations
were taken with a pixel size of 7070 nm, higher magniﬁcations
(insets in Fig. 7) with a pixel size of 5050 nm. Fluorescence was
measured at the 8 bit images of the high magniﬁcation along a
1 pixel thick and 3 mm long line using the “plot proﬁle” tool of the
software ImageJ (vers. 1.48K).
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